Niels B Dalsgaard

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Escherichia Coli

Placebo Controlled

Biofilm Formation

Top Venues

Endocrine connections

European journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Niels B Dalsgaard, Lærke S Gasbjerg, Laura Smidt Hansen, Dennis S Nielsen, Torben S Rasmussen, Filip K Krag Knop
Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover study. Endocrine connections 13 (7) (2024)
Niels B Dalsgaard, Lærke S Gasbjerg, Laura Smidt Hansen, Dennis S Nielsen, Torben S Rasmussen, Filip K Krag Knop
Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover study. Endocrine connections 13 (7) (2024)
Laura Smidt Hansen, Laerke Smidt Gasbjerg, Andreas Brønden, Niels B Dalsgaard, Emilie Bahne, Signe Stensen, Pernille H Hellmann, Jens F Rehfeld, Bolette Hartmann, Nicolai J Wewer Albrechtsen, Jens Juul Holst, Tina Vilsbøll, Filip K Krag Knop
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial. European journal of endocrinology (2024)
Laura Smidt Hansen, Laerke Smidt Gasbjerg, Andreas Brønden, Niels B Dalsgaard, Emilie Bahne, Signe Stensen, Pernille H Hellmann, Jens F Rehfeld, Bolette Hartmann, Nicolai J Wewer Albrechtsen, Jens Juul Holst, Tina Vilsbøll, Filip K Krag Knop
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial. European journal of endocrinology 191 (2) (2024)
Niels B Dalsgaard, Lærke S Gasbjerg, Laura Smidt Hansen, Dennis S Nielsen, Torben S Rasmussen, Filip K Krag Knop
Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover study. Endocrine connections 13 (7) (2024)